MarketPulse

obstructive sleep apnea

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Incannex Healthcare Wins MedTech Prize for Sleep Apnea Drug IHL-42X

Incannex Healthcare wins MedTech Breakthrough Award for IHL-42X sleep apnea therapy, validated by successful Phase 2 trial results showing significant improvements in key endpoints.
IXHLclinical developmentdrug development
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Inspire Medical to Report Q1 2026 Results; Investor Call Set for May 4

Inspire Medical Systems to release Q1 2026 financial results May 4, with management conference call at 5 p.m. ET and two-week webcast replay.
INSPfinancial resultsconference call
GlobeNewswire Inc.GlobeNewswire Inc.··Incannex Healthcare Inc.

Incannex Accelerates Sleep Apnea Drug After FDA Fast Track Win, Phase 2 Success

Incannex Healthcare receives FDA Fast Track Designation for IHL-42X sleep apnea treatment following positive Phase 2 results, plans optimized Phase 3 pathway.
IXHLPhase 2 clinical trialdrug development